官方服务：
资源简介：
ROP vs MDM in preterm babies < 1500g
应用场景：
创建时间：
2020-07-17
相关数据集
Supplementary Material for: Repeat Intravitreal Bevacizumab in a Very Low Birth Weight Infant with Recurrent ROP: 3-Year Follow-Up and Literature Review
Purpose: Low gestational birth weight is associated with increased incidence of Retinopathy of Prematurity (ROP). In recent years, intravitreal injection of anti-vascular endothelial growth factor (VE
DataCite Commons2025-06-13 更新90
Circular RNA Profiling in Peripheral Blood Mononuclear Cells from Retinopathy of Prematurity. Circular RNA Profiling in Peripheral Blood Mononuclear Cells from Retinopathy of Prematurity
To reveal the altered expression profiles of circular RNAs (circRNAs) in the peripheral blood mononuclear cells (PBMCs) of patients with retinopathy of prematurity (ROP), microarray analysis was condu
NIAID Data Ecosystem50
Neonatal characteristics of infants treated with bevacizumab versus the control (2008–2014).
Neonatal characteristics of infants treated with bevacizumab versus the control (2008–2014).
NIAID Data Ecosystem40
Supplementary Material for: Repeat Intravitreal Bevacizumab in a Very Low Birth Weight Infant with Recurrent ROP: 3-Year Follow-Up and Literature Review
Purpose: Low gestational birth weight is associated with increased incidence of Retinopathy of Prematurity (ROP). In recent years, intravitreal injection of anti-vascular endothelial growth factor (VE
DataCite Commons2025-06-13 更新50
A Network Meta-Analysis of Success Rates following Low Dosage Anti-VEGF for Retinopathy of Prematurity
To search the low dosage of anti-VEGF best for primary therapies on retinopathy of prematurity (ROP) in terms of success rate. We searched Medline(Pubmed), Embase, and Cochrane Central Register of Con
DataCite Commons2024-02-09 更新40
